(Press-News.org) The inaugural international guidelines for the diagnosis of rheumatic heart disease (RHD), a disease that affects tens of millions of people worldwide, have today been published by the World Heart Federation in Nature Reviews Cardiology.
The guidelines define the minimum requirements needed to diagnose RHD in individuals without a clear history of acute rheumatic fever (ARF), and will have important global and national implications.
Diagnosis is conducted with an ultrasound of the heart's valves and chambers, known as an echocardiogram, but currently no guidelines are available to define what is normal on echocardiography.
In the absence of definitive guidance, physicians reporting on echocardiograms make decisions based on their clinical experience, and missing the disease at an early stage can have devastating consequences.
"The new evidence-based guidelines clearly define not only what is considered to be a definite and a borderline case of RHD but also what is considered normal in children," said Dr Bo Reményi, Menzies School of Health Research, Darwin, Australia. "The aim of the guidelines is to maximise pick-up of minor degrees of RHD, while preventing over-diagnosis."
The World Heart Federation echocardiographic criteria for RHD have been developed and formulated on the basis of the best available evidence.
"The use of the guidelines should enable rapid identification of RHD patients who do not have a history of ARF," said Prof Jonathan Carapetis, a co-author of the guidelines and Director of the Menzies School of Health Research in Darwin, Australia.
Dr Nigel Wilson a co-author and Paediatric Cardiologist from the Starship Children's Hospital, Auckland New Zealand commented that "the guidelines should also allow for consistent echocardiographic reporting of RHD worldwide, which will in turn help us to get a better understanding of the number of people that are truly affected by this disease."
Three categories have been defined on the basis of assessment by 2D, continuous-wave, and color-Doppler echocardiography: 'definite RHD', 'borderline RHD', and 'normal'. Four subcategories of 'definite RHD' and three subcategories of 'borderline RHD' exist, to reflect the various disease patterns.
### About RHD
RHD, a chronic heart condition in which the heart valves are damaged, is caused by one or more previous bouts of rheumatic fever that can be prevented and controlled. Rheumatic fever is caused by a preceding group A streptococcal (strep) throat infection. Treating strep throat with antibiotics can prevent rheumatic fever. Moreover, regular antibiotics (usually four-weekly injections) can prevent patients with previous rheumatic fever from contracting further attacks of rheumatic fever and hence progression of valve damage.
RHD is a substantial global health problem that can result in irreversible heart damage and premature death. It occurs predominately in developing countries and is also common in poorer populations in middle-income countries (e.g. Brazil, India) and some indigenous populations in wealthy countries (Australia, New Zealand). RHD will continue to be a global problem unless current prevention initiatives are expanded and sustained.
Previous estimates state that more than 15 million people have RHD and that 350,000 people die each year while many more are left disabled.
Developing the Guidelines
An international advisory group of experts in RHD screening and echocardiographic manifestations of RHD was formed in 2009. Under the auspices of the World Heart Federation, this group of 21 investigators from six continents combined their clinical experience with detailed systematic literature review to developed evidence-based echocardiographic diagnostic guidelines for RHD.
The guideline co-authors include Drs Bo Reményi, Nigel Wilson, Andrew Steer, Beatriz Ferreira, Joseph Kado, Krishna Kumar, John Lawrenson, Graeme Maguire, Eloi Marijon, Mariana Mirabel, Ana Olga Mocumbi, Cleonice Mota, John Paar, Anita Saxena, Janet Scheel, John Stirling, Satupaitea Viali, Vijayalakshmi I. Balekundri, Gavin Wheaton, Liesl Zühlke and Jonathan Carapetis.
About the World Heart Federation
The World Heart Federation is dedicated to leading the global fight against heart disease and stroke with a focus on low- and middle-income countries via a united community of more than 200 member organizations. With its members, the World Heart Federation works to build global commitment to addressing cardiovascular health at the policy level, generates and exchanges ideas, shares best practice, advances scientific knowledge and promotes knowledge transfer to tackle cardiovascular disease – the world's number one killer. It is a growing membership organization that brings together the strength of medical societies and heart foundations from more than 100 countries. Through our collective efforts we can help people all over the world to lead longer and better heart-healthy lives. http://www.worldheart.org.
RHD at the World Congress of Cardiology
RHD will be a major topic at the upcoming World Congress of Cardiology Scientific Sessions (WCC) meeting in Dubai, April 18, 2012. The WCC is the official congress of the World Heart Federation and is held every two years. Through the Congress the World Heart Federation offers an international stage for the latest developments in science and public outreach in the field of cardiovascular health. The WCC places emphasis on the complementary nature of science and public outreach and strives to spread the message that through individual, community and patient-care interventions, the growing epidemic of cardiovascular diseases can be prevented. For more information, please visit http://www.worldcardiocongress.org
First international guidelines for echocardiographic diagnosis of rheumatic heart disease
2012-02-29
ELSE PRESS RELEASES FROM THIS DATE:
Molecular duo dictate weight and energy levels
2012-02-29
Yale University researchers have discovered a key cellular mechanism that may help the brain control how much we eat, what we weigh, and how much energy we have.
The findings, published in the Feb. 28 issue of the Journal of Neuroscience, describe the regulation of a family of cells that project throughout the nervous system and originate in an area of the brain call the hypothalamus, which has been long known to control energy balances.
Scientists and pharmaceutical companies are closely investigating the role of melanin-concentrating hormone (MCH) neurons in controlling ...
Tomb exploration reveals first archaeological evidence of Christianity from the time of Jesus
2012-02-29
The archaeological examination by robotic camera of an intact first century tomb in Jerusalem has revealed a set of limestone Jewish ossuaries or "bone boxes" that are engraved with a rare Greek inscription and a unique iconographic image that the scholars involved identify as distinctly Christian.
The four-line Greek inscription on one ossuary refers to God "raising up" someone and a carved image found on an adjacent ossuary shows what appears to be a large fish with a human stick figure in its mouth, interpreted by the excavation team to be an image evoking the biblical ...
New 'magnetic yeast' marks step toward harnessing Nature's magnetic capabilities
2012-02-29
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School have developed a method for inducing magnetic sensitivity in an organism that is not naturally magnetic—yeast. Their technology could potentially be used to magnetize a variety of different cell types in medical, industrial and research applications. The research findings appear in today's issue of PLoS Biology.
Magnetic fields are everywhere, but few organisms can sense them. Those that do, such as birds and butterflies, use magnetic sensitivity as ...
Shula Burger Selects Napa Technology as Exclusive Wine Preservation Equipment Partner; Legendary Restaurant Group to Use WineStation in 100 Unit Development Plans
2012-02-29
No stranger to making smart picks, the Shula Restaurant group identified Napa Technology as their exclusive wine preservation and dispensing equipment partner in their latest concept; Shula Burger. This fast casual concept is shaking up the burger business by focusing on gourmet burgers designed to be paired with a broad collection of wines. The selection of Napa Technology, makers of the WineStation intelligent dispensing systems, signifies the degree of importance the brand will be placing on its wine program.
"This is an exciting concept that will cater to ...
Report examines what US can learn from EU chemicals law
2012-02-29
BLOOMINGTON, Ind. -- U.S. industry and environmental groups agree that the Toxic Substances Control Act (TSCA) of 1976 needs to be modernized to better protect public health and the environment. However, there is no consensus on what the reform should look like.
A new report from Indiana University supplies a close examination of the European Union's reformed chemicals law REACH (Registration, Evaluation, Authorization and Restriction of Chemicals), which went into effect in 2006.
After reviewing data and interviewing key stakeholders, including manufacturers, importers ...
Future smart phones will project images on the wall
2012-02-29
Mobile phones currently on the market are capable of showing high quality images and video, but the phones' small size sets insurmountable limits on screen size, and thus the viewing experience. VTT Technical Research Centre of Finland, EpiCrystals Oy and the Aalto University are developing a better laser light source for projectors that will be integrated into mobile phones, which will enable accurate and efficient projection of, for example, photographs and movies on any surface. Mobile phones equipped with the laser light source can be within the ordinary consumer's ...
Optogenetic tool elucidated
2012-02-29
Controlling nerve cells with the aid of light: this is made possible by optogenetics. It enables, for example, the investigation of neurobiological processes with unprecedented spatial and temporal precision. The key tool of optogenetics is the light-activated protein channelrhodopsin. Biophysicists from Bochum and Berlin have now succeeded in explaining the switching mechanism through an interdisciplinary approach. The researchers report on their findings in the Journal of Biological Chemistry.
Redistribution of water molecules
Until now, little has been known about ...
New discoveries on depression
2012-02-29
During depression, the brain becomes less plastic and adaptable, and thus less able to perform certain tasks, like storing memories. Researchers at the Swedish medical university Karolinska Institutet have now traced the brain's lower plasticity to reduced functionality in its support cells, and believe that learning more about these cells can pave the way for radical new therapies for depression.
"We were able to cure memory dysfunction in 'depressed' rats by giving them doses of D-serine," says Mia Lindskog, biologist and Assistant Professor at Karolinska Institutet's ...
Clean delivery kits linked to substantial reduction in neonatal deaths in South Asia, study shows
2012-02-29
Providing clean delivery kits and improving birthing practices could halve the number of neonatal deaths following home births in South Asia, according to research funded by the Wellcome Trust.
Around half a million babies die in the first month of life from sepsis and around a third of these infections are transmitted at the time of birth. In South Asia, more than half of deliveries occur at home, most without skilled birth attendance. Maintaining clean delivery practices at home can be challenging for mothers and their birthing companions.
One way to potentially ...
Clinical guide on selective estrogen receptor modulators for postmenopausal osteoporosis
2012-02-29
Amsterdam, February 28, 2012 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the publication of an important clinical guide from the European Menopause and Andropause Society (EMAS) in the February issue of Maturitas. This clinical guide details the role of selective estrogen receptor modulators (SERMs) against postmenopausal osteoporosis as the European Medicines Agency (EMA) has approved the use of bazedoxifene and lasofoxifene.
Postmenopausal osteoporosis and resulting fractures have a major ...